New Positions
0 managers initiated
Top five by reported value
No new institutional positions this quarter.
Acurx Pharmaceuticals Inc NASDAQ NMS - GLOBAL MARKET:ACXP
Institutional holders, quarter-over-quarter share deltas, and new and closed positions disclosed in Form 13F. Period 2025-09-30 · prior 2025-06-30.
0 new0 added2 reduced32 exited
Total Institutional Holders
1
as of 2025-09-30
Top Holder
ADVISOR GROUP HOLDINGS, INC.
$2.4K
Largest QoQ Increase
—
Largest QoQ Decrease
ARMISTICE CAPITAL, LLC
-1,078,540 sh
Reduced(2)
| Manager | Shares | Δ Shares | Value | Δ Value | % Δ |
|---|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 7,582 | -3,218 | $2.4K | -$6.3K | -29.8% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | 0 | $0 | $0 | — |
Sold Out(32)
Top Holders by reported value
Ranked by the dollar value reported on the latest Form 13F. Share counts reflect long positions as of 2025-09-30.
| Manager | Shares | $ Value | Δ Shares | QoQ % |
|---|---|---|---|---|
| ADVISOR GROUP HOLDINGS, INC. | 7,582 | $2.4K | -3,218 | -29.8% |
New & Closed Positions this quarter
Closed Positions
32 managers exited
Top five by prior-quarter value
- ARMISTICE CAPITAL, LLC$550.9K
- Prospect Financial Services LLC$151.6K
- GEODE CAPITAL MANAGEMENT, LLC$74.8K
- VANGUARD GROUP INC$74.4K
- CITADEL ADVISORS LLC$61.1K
Methodology
Form 13F is the SEC's quarterly disclosure for institutional investment managers exercising discretion over $100 million or more in qualifying U.S. equity securities. Managers must file within 45 days of each calendar quarter end, which is why holdings shown here reflect a snapshot at the period date — not real-time positioning.
Quarter-over-quarter deltas compare each manager's most recently reported share count for ACXP against its prior-quarter count. New positions are entries where the prior count was zero; closed positions are entries where the current count is zero. Amendments (13F-HR/A) replace prior filings for the same period.
Source: SEC EDGAR Form 13F (XML information tables). Dollar values are as reported by the manager and may use mid-quarter pricing conventions. CUSIP-to-ticker resolution is best-effort.